Next print: September's consumer prices, about 12 October
India Atlas Search /
Guides / National Family Health Survey, NFHS / Every cut

India and every state and UT, urban, rural and total: the 101 indicators of the NFHS-6 fact sheets, base NFHS-6 (2023-24)

10,600 series, each with its latest value, its change on a year earlier and its trend. Page 6 of 12.

Source IIPS and the Ministry of Health and Family Welfare, NFHS-6 (2023-24) fact sheets Base NFHS-6 (2023-24) Frequency cross-sectional Vintage 2026-05-27 Download CSV, JSON
957 series
Trend Data
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), All IndiaAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 71.8%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), All India, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 71.3%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), All India, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 72.0%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Andhra PradeshAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 84.1%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Andhra Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 75.7%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Andhra Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 87.8%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Arunachal PradeshAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 65.7%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Arunachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 60.9%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Arunachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 68.3%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), AssamAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 68.1%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Assam, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 75.9%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Assam, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 67.5%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), BiharAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 66.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Bihar, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 61.4%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Bihar, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 66.6%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), ChhattisgarhAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 64.1%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Chhattisgarh, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 71.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Chhattisgarh, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 62.7%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), GoaAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 88.3%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Goa, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 80.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Goa, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 97.0%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), GujaratAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 70.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Gujarat, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 69.9%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Gujarat, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 70.3%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), HaryanaAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 73.9%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Haryana, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 78.4%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Haryana, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 71.7%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Himachal PradeshAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 77.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Himachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 76.7%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Himachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 77.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), JharkhandAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 70.7%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Jharkhand, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 72.3%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Jharkhand, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 70.4%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), KarnatakaAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 79.4%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Karnataka, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 78.6%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Karnataka, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 80.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), KeralaAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 83.3%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Kerala, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 84.1%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Kerala, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 82.4%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Madhya PradeshAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 67.0%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Madhya Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 72.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Madhya Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 65.5%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), MaharashtraAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 66.7%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Maharashtra, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 64.6%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Maharashtra, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 68.1%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), MeghalayaAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 60.0%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Meghalaya, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 56.3%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Meghalaya, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 60.5%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), MizoramAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 59.6%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Mizoram, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 61.9%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Mizoram, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 57.8%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), NagalandAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 62.7%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Nagaland, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 63.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Nagaland, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 62.5%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), OdishaAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 86.3%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Odisha, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 89.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Odisha, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 85.9%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), PunjabAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 60.7%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Punjab, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 61.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Punjab, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 60.4%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), RajasthanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 57.6%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Rajasthan, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 67.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Rajasthan, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 55.4%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), SikkimAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 85.6%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Sikkim, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 82.1%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Tamil NaduAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 75.6%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Tamil Nadu, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 74.3%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Tamil Nadu, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 76.4%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), TelanganaAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 78.6%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Telangana, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 76.1%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Telangana, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 79.5%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), TripuraAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 62.0%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Tripura, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 77.3%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Tripura, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 59.8%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Uttar PradeshAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 72.6%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Uttar Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 67.1%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Uttar Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 74.0%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), UttarakhandAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 83.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Uttarakhand, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 85.9%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Uttarakhand, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 82.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), West BengalAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 86.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), West Bengal, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 77.9%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), West Bengal, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 89.0%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Andaman and Nicobar IslandsAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 90.9%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Andaman and Nicobar Islands, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 92.6%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), ChandigarhAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 91.8%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Chandigarh, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 91.6%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Dadra & Nagar Haveli and Daman & DiuAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 80.8%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Dadra & Nagar Haveli and Daman & Diu, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 71.0%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Dadra & Nagar Haveli and Daman & Diu, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 88.9%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Jammu and KashmirAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 82.4%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Jammu and Kashmir, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 85.8%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Jammu and Kashmir, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 81.7%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), LadakhAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 85.7%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Ladakh, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 83.0%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), LakshadweepAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 37.2%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Lakshadweep, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 49.3%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), NCT of DelhiAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 61.7%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), NCT of Delhi, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 61.7%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), PuducherryAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 85.0%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Puducherry, urbanAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 87.0%NFHS-6, 2023-24 — CSV
Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV), Puducherry, ruralAll India, base NFHS-6 (2023-24) Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) 81.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, All IndiaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 77.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, All India, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 80.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, All India, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 76.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Andhra PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 91.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Andhra Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 91.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Andhra Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 92.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Arunachal PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 74.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Arunachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 82.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Arunachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 71.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, AssamAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 71.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Assam, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 75.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Assam, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 71.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, BiharAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 74.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Bihar, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 81.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Bihar, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 74.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, ChhattisgarhAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 77.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Chhattisgarh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 82.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Chhattisgarh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 76.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, GoaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 91.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Goa, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 91.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Goa, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 92.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, GujaratAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 86.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Gujarat, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 84.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Gujarat, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 87.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, HaryanaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 84.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Haryana, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 86.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Haryana, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 83.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Himachal PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 91.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Himachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 85.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Himachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 91.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, JharkhandAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 65.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Jharkhand, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 69.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Jharkhand, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 65.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, KarnatakaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 92.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Karnataka, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 90.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Karnataka, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 93.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, KeralaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 86.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Kerala, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 89.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Kerala, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 84.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Madhya PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 86.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Madhya Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 87.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Madhya Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 86.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, MaharashtraAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 76.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Maharashtra, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 74.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Maharashtra, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 77.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, MeghalayaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 67.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Meghalaya, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 74.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Meghalaya, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 66.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, MizoramAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 88.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Mizoram, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 91.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Mizoram, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 85.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, NagalandAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 46.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Nagaland, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 57.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Nagaland, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 41.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, OdishaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 89.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Odisha, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 85.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Odisha, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 90.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, PunjabAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 80.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Punjab, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 79.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Punjab, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 81.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, RajasthanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 82.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Rajasthan, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 89.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Rajasthan, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 80.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, SikkimAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 94.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Sikkim, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 94.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Tamil NaduAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 90.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Tamil Nadu, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 87.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Tamil Nadu, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 92.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, TelanganaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 88.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Telangana, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 91.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Telangana, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 88.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, TripuraAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 75.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Tripura, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 89.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Tripura, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 72.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Uttar PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 57.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Uttar Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 56.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Uttar Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 57.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, UttarakhandAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 79.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Uttarakhand, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 85.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Uttarakhand, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 77.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, West BengalAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 89.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, West Bengal, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 89.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, West Bengal, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 88.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Andaman and Nicobar IslandsAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 96.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Andaman and Nicobar Islands, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 94.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, ChandigarhAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 99.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Chandigarh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 98.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Dadra & Nagar Haveli and Daman & DiuAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 95.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Dadra & Nagar Haveli and Daman & Diu, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 90.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Dadra & Nagar Haveli and Daman & Diu, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 100.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Jammu and KashmirAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 94.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Jammu and Kashmir, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 96.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Jammu and Kashmir, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 93.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, LadakhAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 98.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Ladakh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 99.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, LakshadweepAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 83.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Lakshadweep, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 82.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, NCT of DelhiAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 73.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, NCT of Delhi, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 73.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, PuducherryAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 92.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Puducherry, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 88.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received birth dose of hepatitis B vaccine, Puducherry, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received birth dose of hepatitis B vaccine 98.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, All IndiaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 85.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, All India, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 84.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, All India, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 85.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Andhra PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 92.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Andhra Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 89.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Andhra Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 94.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Arunachal PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 79.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Arunachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 76.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Arunachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 80.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, AssamAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Assam, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Assam, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, BiharAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 84.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Bihar, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 79.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Bihar, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 84.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, ChhattisgarhAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 83.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Chhattisgarh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 86.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Chhattisgarh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 83.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, GoaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 97.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Goa, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 94.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Goa, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 100.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, GujaratAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 80.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Gujarat, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 82.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Gujarat, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 78.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, HaryanaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 86.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Haryana, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Haryana, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 86.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Himachal PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 90.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Himachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 78.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Himachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 91.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, JharkhandAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 84.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Jharkhand, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Jharkhand, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 84.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, KarnatakaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 84.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Karnataka, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Karnataka, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 82.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, KeralaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Kerala, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 88.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Kerala, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 86.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Madhya PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 86.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Madhya Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 90.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Madhya Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 85.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, MaharashtraAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Maharashtra, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 86.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Maharashtra, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, MeghalayaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 77.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Meghalaya, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Meghalaya, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 75.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, MizoramAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 85.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Mizoram, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 86.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Mizoram, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 84.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, NagalandAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 68.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Nagaland, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 67.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Nagaland, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 68.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, OdishaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 89.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Odisha, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 82.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Odisha, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 90.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, PunjabAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 80.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Punjab, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 79.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Punjab, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 80.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, RajasthanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 83.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Rajasthan, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 88.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Rajasthan, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 82.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, SikkimAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 94.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Sikkim, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 96.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Tamil NaduAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Tamil Nadu, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Tamil Nadu, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, TelanganaAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 63.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Telangana, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 65.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Telangana, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 63.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, TripuraAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 79.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Tripura, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 91.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Tripura, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 78.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Uttar PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 85.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Uttar Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 79.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Uttar Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, UttarakhandAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 92.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Uttarakhand, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 94.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Uttarakhand, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 92.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, West BengalAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 92.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, West Bengal, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 88.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, West Bengal, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 93.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Andaman and Nicobar IslandsAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 76.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Andaman and Nicobar Islands, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 74.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, ChandigarhAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 93.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Chandigarh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 93.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Dadra & Nagar Haveli and Daman & DiuAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 93.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Dadra & Nagar Haveli and Daman & Diu, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 87.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Dadra & Nagar Haveli and Daman & Diu, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 99.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Jammu and KashmirAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 91.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Jammu and Kashmir, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 90.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Jammu and Kashmir, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 91.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, LadakhAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 92.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Ladakh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 91.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, LakshadweepAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 22.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Lakshadweep, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 36.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, NCT of DelhiAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 67.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, NCT of Delhi, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 68.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, PuducherryAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 88.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Puducherry, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 81.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who have received 3 doses of rotavirus vaccine, Puducherry, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who have received 3 doses of rotavirus vaccine 98.2%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, All IndiaAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 74.6%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, All India, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 77.1%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, All India, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 73.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Andhra PradeshAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 91.3%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Andhra Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 89.8%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Andhra Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 92.0%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Arunachal PradeshAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 74.9%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Arunachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 78.6%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Arunachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 73.0%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, AssamAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 78.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Assam, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 81.6%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Assam, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 78.2%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, BiharAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 61.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Bihar, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 61.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Bihar, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 61.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, ChhattisgarhAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 79.9%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Chhattisgarh, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 83.9%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Chhattisgarh, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 79.1%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, GoaAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 91.2%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Goa, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 91.9%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Goa, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 90.4%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, GujaratAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 84.0%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Gujarat, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 83.8%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Gujarat, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 84.1%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, HaryanaAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 73.4%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Haryana, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 73.9%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Haryana, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 73.2%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Himachal PradeshAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 82.4%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Himachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 86.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Himachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 81.9%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, JharkhandAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 65.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Jharkhand, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 67.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Jharkhand, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 65.2%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, KarnatakaAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 89.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Karnataka, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 88.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Karnataka, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 90.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, KeralaAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 84.3%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Kerala, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 82.2%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Kerala, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 86.2%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Madhya PradeshAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 79.3%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Madhya Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 82.4%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Madhya Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 78.4%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, MaharashtraAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 84.0%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Maharashtra, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 87.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Maharashtra, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 81.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, MeghalayaAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 77.0%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Meghalaya, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 79.4%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Meghalaya, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 76.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, MizoramAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 80.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Mizoram, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 82.6%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Mizoram, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 78.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, NagalandAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 56.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Nagaland, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 51.9%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Nagaland, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 58.3%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, OdishaAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 82.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Odisha, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 82.9%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Odisha, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 82.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, PunjabAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 78.1%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Punjab, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 77.1%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Punjab, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 78.8%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, RajasthanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 65.6%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Rajasthan, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 69.2%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Rajasthan, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 64.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, SikkimAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 86.3%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Sikkim, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 87.6%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Sikkim, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 86.0%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Tamil NaduAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 71.4%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Tamil Nadu, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 69.9%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Tamil Nadu, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 72.4%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, TelanganaAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 90.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Telangana, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 90.1%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Telangana, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 90.6%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, TripuraAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 78.0%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Tripura, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 93.9%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Tripura, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 75.8%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Uttar PradeshAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 65.4%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Uttar Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 61.3%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Uttar Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 66.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, UttarakhandAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 59.9%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Uttarakhand, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 54.9%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Uttarakhand, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 61.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, West BengalAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 88.0%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, West Bengal, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 86.6%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, West Bengal, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 88.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Andaman and Nicobar IslandsAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 64.0%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Andaman and Nicobar Islands, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 59.2%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Andaman and Nicobar Islands, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 68.0%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, ChandigarhAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 75.6%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Chandigarh, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 76.2%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Dadra & Nagar Haveli and Daman & DiuAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 92.3%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Dadra & Nagar Haveli and Daman & Diu, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 89.4%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Dadra & Nagar Haveli and Daman & Diu, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 95.1%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Jammu and KashmirAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 84.0%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Jammu and Kashmir, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 85.8%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Jammu and Kashmir, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 83.6%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, LadakhAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 84.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Ladakh, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 81.5%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Ladakh, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 85.3%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, LakshadweepAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 39.6%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Lakshadweep, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 47.3%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Lakshadweep, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 30.3%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, NCT of DelhiAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 75.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, NCT of Delhi, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 75.6%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, NCT of Delhi, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 81.8%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, PuducherryAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 85.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Puducherry, urbanAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 88.7%NFHS-6, 2023-24 — CSV
Children age 9-35 months who received a vitamin A dose in the last 6 months, Puducherry, ruralAll India, base NFHS-6 (2023-24) Children age 9-35 months who received a vitamin A dose in the last 6 months 81.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, All IndiaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 95.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, All India, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 90.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, All India, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Andhra PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 94.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Andhra Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 90.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Andhra Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 96.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Arunachal PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Arunachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Arunachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, AssamAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 95.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Assam, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 88.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Assam, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 96.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, BiharAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 96.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Bihar, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 90.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Bihar, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, ChhattisgarhAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 98.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Chhattisgarh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 94.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Chhattisgarh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 98.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, GoaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 94.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Goa, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 92.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Goa, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 96.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, GujaratAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 92.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Gujarat, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 86.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Gujarat, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 96.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, HaryanaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 94.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Haryana, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 89.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Haryana, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 96.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Himachal PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Himachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 86.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Himachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 98.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, JharkhandAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Jharkhand, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 86.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Jharkhand, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 98.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, KarnatakaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 90.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Karnataka, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 82.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Karnataka, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 96.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, KeralaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 95.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Kerala, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 93.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Kerala, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 96.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Madhya PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Madhya Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 93.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Madhya Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 98.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, MaharashtraAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 95.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Maharashtra, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 91.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Maharashtra, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, MeghalayaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 94.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Meghalaya, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 81.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Meghalaya, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 96.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, MizoramAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 96.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Mizoram, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 95.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Mizoram, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 98.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, NagalandAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 83.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Nagaland, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 79.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Nagaland, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 85.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, OdishaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 98.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Odisha, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 95.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Odisha, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 99.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, PunjabAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 94.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Punjab, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 93.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Punjab, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 95.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, RajasthanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Rajasthan, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 95.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Rajasthan, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 98.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, SikkimAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 100.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Sikkim, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 100.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Tamil NaduAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 91.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Tamil Nadu, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 86.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Tamil Nadu, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 95.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, TelanganaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 95.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Telangana, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 91.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Telangana, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, TripuraAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 98.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Tripura, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 94.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Tripura, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 99.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Uttar PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 94.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Uttar Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 88.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Uttar Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 96.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, UttarakhandAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 95.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Uttarakhand, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 88.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Uttarakhand, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, West BengalAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 98.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, West Bengal, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, West Bengal, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 99.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Andaman and Nicobar IslandsAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 95.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Andaman and Nicobar Islands, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 100.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, ChandigarhAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 93.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Chandigarh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 92.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Dadra & Nagar Haveli and Daman & DiuAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 100.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Dadra & Nagar Haveli and Daman & Diu, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 100.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Dadra & Nagar Haveli and Daman & Diu, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 100.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Jammu and KashmirAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 97.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Jammu and Kashmir, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 91.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Jammu and Kashmir, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 99.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, LadakhAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 98.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Ladakh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 99.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, LakshadweepAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 99.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Lakshadweep, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 98.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, NCT of DelhiAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 94.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, NCT of Delhi, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 94.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, PuducherryAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 92.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Puducherry, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 85.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a public health facility, Puducherry, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a public health facility 100.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, All IndiaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 3.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, All India, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 8.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, All India, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 1.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, AssamAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 1.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Assam, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 8.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Assam, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 1.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, BiharAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 2.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Bihar, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 10.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Bihar, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 1.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, ChhattisgarhAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 1.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Chhattisgarh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 3.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Chhattisgarh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 0.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, HaryanaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 4.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Haryana, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 8.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Haryana, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 2.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Himachal PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 2.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Himachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 8.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Himachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 1.4%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, JharkhandAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 2.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Jharkhand, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 12.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Jharkhand, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 0.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, KarnatakaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 8.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Karnataka, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 16.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Karnataka, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 3.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, KeralaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 4.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Kerala, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 5.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Kerala, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 3.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Madhya PradeshAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 1.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Madhya Pradesh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 5.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Madhya Pradesh, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 0.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, MaharashtraAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 3.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Maharashtra, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 6.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Maharashtra, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 2.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, MeghalayaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 3.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Meghalaya, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 16.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Meghalaya, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 1.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, MizoramAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 2.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Mizoram, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 4.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Mizoram, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 0.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, NagalandAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 12.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Nagaland, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 20.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Nagaland, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 9.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, OdishaAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 0.7%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Odisha, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 3.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Odisha, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 0.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, PunjabAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 4.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Punjab, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 5.6%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Punjab, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 4.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, ChandigarhAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 6.8%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Chandigarh, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 7.3%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, LakshadweepAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 0.9%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Lakshadweep, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 1.5%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, NCT of DelhiAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 5.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, NCT of Delhi, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 5.1%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, PuducherryAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 8.0%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Puducherry, urbanAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 14.2%NFHS-6, 2023-24 — CSV
Children age 12-23 months who received most of their vaccinations in a private health facility, Puducherry, ruralAll India, base NFHS-6 (2023-24) Children age 12-23 months who received most of their vaccinations in a private health facility 0.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, All IndiaAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 7.9%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, All India, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 6.7%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, All India, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 8.3%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Andhra PradeshAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.8%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Andhra Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.4%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Andhra Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.9%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Arunachal PradeshAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 3.8%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Arunachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 2.7%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Arunachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.3%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, AssamAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 1.9%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Assam, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 1.4%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Assam, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 2.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, BiharAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 7.7%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Bihar, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.6%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Bihar, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 8.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, ChhattisgarhAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 7.4%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Chhattisgarh, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 9.6%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Chhattisgarh, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 6.9%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, GoaAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 0.7%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Goa, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 1.3%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Goa, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, GujaratAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.7%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Gujarat, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Gujarat, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 6.2%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, HaryanaAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 10.7%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Haryana, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 10.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Haryana, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 10.7%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Himachal PradeshAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.6%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Himachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.3%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Himachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, JharkhandAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 10.3%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Jharkhand, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 9.2%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Jharkhand, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 10.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, KarnatakaAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 6.2%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Karnataka, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.8%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Karnataka, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 6.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, KeralaAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.6%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Kerala, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.8%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Kerala, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Madhya PradeshAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 10.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Madhya Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 10.8%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Madhya Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 10.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, MaharashtraAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.9%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Maharashtra, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Maharashtra, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 7.2%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, MeghalayaAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 3.6%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Meghalaya, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.9%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Meghalaya, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 3.4%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, MizoramAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 2.2%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Mizoram, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 2.4%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Mizoram, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 2.1%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, NagalandAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 3.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Nagaland, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 2.6%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Nagaland, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 3.2%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, OdishaAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 11.2%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Odisha, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 9.4%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Odisha, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 11.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, PunjabAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Punjab, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.2%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Punjab, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.6%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, RajasthanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.8%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Rajasthan, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Rajasthan, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 6.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, SikkimAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 2.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Sikkim, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 2.4%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Sikkim, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 2.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Tamil NaduAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.1%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Tamil Nadu, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.4%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Tamil Nadu, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.6%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, TelanganaAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Telangana, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.6%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Telangana, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, TripuraAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Tripura, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 1.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Tripura, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Uttar PradeshAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 13.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Uttar Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 11.9%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Uttar Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 13.2%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, UttarakhandAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 10.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Uttarakhand, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 12.2%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Uttarakhand, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 9.2%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, West BengalAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 2.9%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, West Bengal, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 2.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, West Bengal, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 3.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Andaman and Nicobar IslandsAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 1.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Andaman and Nicobar Islands, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Andaman and Nicobar Islands, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 2.8%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, ChandigarhAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 6.3%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Chandigarh, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 6.1%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Dadra & Nagar Haveli and Daman & DiuAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 3.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Dadra & Nagar Haveli and Daman & Diu, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 1.5%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Dadra & Nagar Haveli and Daman & Diu, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.3%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Jammu and KashmirAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.1%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Jammu and Kashmir, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 3.6%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Jammu and Kashmir, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 4.3%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, LadakhAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Ladakh, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 1.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Ladakh, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, LakshadweepAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 9.3%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Lakshadweep, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 3.3%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Lakshadweep, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 16.1%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, NCT of DelhiAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 8.8%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, NCT of Delhi, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 8.9%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, NCT of Delhi, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 3.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, PuducherryAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 6.0%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Puducherry, urbanAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 5.3%NFHS-6, 2023-24 — CSV
Prevalence of diarrhoea in the 2 weeks preceding the survey, Puducherry, ruralAll India, base NFHS-6 (2023-24) Prevalence of diarrhoea in the 2 weeks preceding the survey 6.9%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, All IndiaAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, All India, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, All India, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Andhra PradeshAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.1%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Andhra Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Andhra Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Arunachal PradeshAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Arunachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Arunachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, AssamAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Assam, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Assam, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, BiharAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Bihar, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Bihar, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, ChhattisgarhAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Chhattisgarh, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Chhattisgarh, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, GoaAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Goa, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Goa, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, GujaratAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Gujarat, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Gujarat, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, HaryanaAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Haryana, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Haryana, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.8%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Himachal PradeshAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Himachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Himachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, JharkhandAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Jharkhand, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Jharkhand, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.7%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, KarnatakaAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 1.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Karnataka, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 1.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Karnataka, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 1.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, KeralaAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Kerala, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Kerala, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Madhya PradeshAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.7%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Madhya Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Madhya Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.8%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, MaharashtraAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Maharashtra, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Maharashtra, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, MeghalayaAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.7%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Meghalaya, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 1.7%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Meghalaya, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, MizoramAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Mizoram, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Mizoram, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.1%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, NagalandAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.1%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Nagaland, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Nagaland, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, OdishaAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.9%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Odisha, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Odisha, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 1.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, PunjabAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Punjab, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Punjab, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.1%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, RajasthanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Rajasthan, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Rajasthan, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, SikkimAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Sikkim, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Sikkim, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Tamil NaduAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Tamil Nadu, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Tamil Nadu, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, TelanganaAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Telangana, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Telangana, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, TripuraAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Tripura, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Tripura, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Uttar PradeshAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 1.1%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Uttar Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.9%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Uttar Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 1.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, UttarakhandAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 1.1%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Uttarakhand, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 1.9%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Uttarakhand, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.7%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, West BengalAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, West Bengal, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, West Bengal, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Andaman and Nicobar IslandsAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Andaman and Nicobar Islands, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Andaman and Nicobar Islands, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, ChandigarhAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Chandigarh, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Dadra & Nagar Haveli and Daman & DiuAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Dadra & Nagar Haveli and Daman & Diu, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Dadra & Nagar Haveli and Daman & Diu, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Jammu and KashmirAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Jammu and Kashmir, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Jammu and Kashmir, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, LadakhAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Ladakh, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Ladakh, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, LakshadweepAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Lakshadweep, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Lakshadweep, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, NCT of DelhiAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, NCT of Delhi, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, NCT of Delhi, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, PuducherryAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.1%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Puducherry, urbanAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.1%NFHS-6, 2023-24 — CSV
Prevalence of severe diarrhoea in the 2 weeks preceding the survey, Puducherry, ruralAll India, base NFHS-6 (2023-24) Prevalence of severe diarrhoea in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, All IndiaAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.9%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, All India, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, All India, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Andhra PradeshAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Andhra Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.7%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Andhra Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.1%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Arunachal PradeshAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Arunachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Arunachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.7%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, AssamAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Assam, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.9%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Assam, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, BiharAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 3.2%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Bihar, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Bihar, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 3.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, ChhattisgarhAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.7%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Chhattisgarh, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Chhattisgarh, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.8%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, GoaAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Goa, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Goa, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.5%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, GujaratAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.8%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Gujarat, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.8%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Gujarat, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.7%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, HaryanaAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.2%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Haryana, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.7%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Haryana, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Himachal PradeshAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Himachal Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.9%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Himachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, JharkhandAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Jharkhand, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Jharkhand, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.5%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, KarnatakaAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.8%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Karnataka, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Karnataka, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.9%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, KeralaAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.8%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Kerala, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 3.1%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Kerala, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.6%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Madhya PradeshAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Madhya Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Madhya Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, MaharashtraAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.8%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Maharashtra, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.6%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Maharashtra, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, MeghalayaAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Meghalaya, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.1%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Meghalaya, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, MizoramAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Mizoram, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Mizoram, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, NagalandAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Nagaland, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Nagaland, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, OdishaAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.2%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Odisha, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.1%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Odisha, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.2%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, PunjabAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Punjab, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Punjab, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, RajasthanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.7%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Rajasthan, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.6%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Rajasthan, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.5%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, SikkimAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Sikkim, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Sikkim, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Tamil NaduAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.6%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Tamil Nadu, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Tamil Nadu, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.9%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, TelanganaAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Telangana, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.5%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Telangana, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, TripuraAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Tripura, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Tripura, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Uttar PradeshAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.6%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Uttar Pradesh, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.1%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Uttar Pradesh, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.7%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, UttarakhandAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.9%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Uttarakhand, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Uttarakhand, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 3.1%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, West BengalAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, West Bengal, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.1%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, West Bengal, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.5%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Andaman and Nicobar IslandsAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.2%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Andaman and Nicobar Islands, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Andaman and Nicobar Islands, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, ChandigarhAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.0%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Chandigarh, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.1%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Dadra & Nagar Haveli and Daman & DiuAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Dadra & Nagar Haveli and Daman & Diu, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Dadra & Nagar Haveli and Daman & Diu, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Jammu and KashmirAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.1%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Jammu and Kashmir, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.1%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Jammu and Kashmir, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, LadakhAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Ladakh, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Ladakh, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, LakshadweepAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 2.8%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Lakshadweep, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.5%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Lakshadweep, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 4.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, NCT of DelhiAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, NCT of Delhi, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.3%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, NCT of Delhi, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.4%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, PuducherryAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.8%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Puducherry, urbanAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 1.5%NFHS-6, 2023-24 — CSV
Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey, Puducherry, ruralAll India, base NFHS-6 (2023-24) Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey 0.0%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, All IndiaAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 68.8%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, All India, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 74.8%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, All India, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 67.3%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, AssamAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 44.4%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Assam, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 51.2%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Assam, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 43.8%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, BiharAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 65.7%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Bihar, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 61.9%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Bihar, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 66.0%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, ChhattisgarhAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 77.0%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Chhattisgarh, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 79.6%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Chhattisgarh, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 76.5%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, HaryanaAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 74.6%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Haryana, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 76.4%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Haryana, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 73.8%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Himachal PradeshAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 74.6%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Himachal Pradesh, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 75.1%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, JharkhandAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 55.5%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Jharkhand, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 65.9%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Jharkhand, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 53.8%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, KarnatakaAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 80.3%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Karnataka, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 82.8%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Karnataka, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 78.8%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, KeralaAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 79.0%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Kerala, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 78.6%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Kerala, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 79.3%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Madhya PradeshAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 74.7%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Madhya Pradesh, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 78.1%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Madhya Pradesh, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 73.6%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, MaharashtraAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 75.6%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Maharashtra, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 73.2%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Maharashtra, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 76.9%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, MeghalayaAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 65.3%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Meghalaya, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 66.4%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Meghalaya, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 65.2%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, MizoramAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 42.2%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Mizoram, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 46.0%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Mizoram, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 35.4%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, NagalandAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 34.0%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Nagaland, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 41.7%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Nagaland, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 30.4%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, OdishaAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 69.5%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Odisha, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 72.1%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Odisha, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 69.2%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, PunjabAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 86.9%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Punjab, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 89.1%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Punjab, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 85.6%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Uttar PradeshAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 64.6%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Uttar Pradesh, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 75.3%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Uttar Pradesh, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 62.4%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, UttarakhandAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 74.8%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Uttarakhand, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 81.3%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Uttarakhand, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 72.5%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Andaman and Nicobar IslandsAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 69.4%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Andaman and Nicobar Islands, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 85.3%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, ChandigarhAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 92.1%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Chandigarh, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 91.6%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, LakshadweepAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 81.6%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Lakshadweep, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 78.8%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Lakshadweep, ruralAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 83.6%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, NCT of DelhiAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 73.0%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, NCT of Delhi, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 73.6%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, PuducherryAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 77.4%NFHS-6, 2023-24 — CSV
Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider, Puducherry, urbanAll India, base NFHS-6 (2023-24) Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider 75.8%NFHS-6, 2023-24 — CSV

Back to the guide: Family health